Tag: CX 2022
Contemporary venous intervention reduces post-thrombotic syndrome in initial CLEAR-DVT analysis
In an initial cohort of patients enrolled in the CLEAR-DVT study, contemporary venous intervention resulted in an open vein, which reduced post-thrombotic syndrome (PTS)....
Overtreatment in venous disease: Financial incentives are “the elephant in the...
To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...
CX 2022 venous and lymphatic challenges: “We are at a turning...
This year’s venous and lymphatic programme at the Charing Cross (CX) International Symposium 2022 (26–28 April, London, UK, in person and virtual) will cover...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...